Skip to main content
. 2014 Dec 2;3(1):42–48. doi: 10.1002/sm2.51

Table 1.

Comorbidities of the population at the time of radical prostatectomy and tumor status

N (%)
Comorbidities
 Diabetes (type 2) 6 (8)
 Dyslipidemia 16 (21.3)
 BMI, mean ± SD (kg/m2) 25.6 ± 2.6
 Tobacco smoking 4 (5.3)
 Hypertension 25 (33.3)
 Coronary artery disease 5 (6.6)
Tumor status
 pT2 70 (93.3)
 pT3a 5 (6.7)
 Gleason VI 16 (21.3)
 Gleason VII 51 (68)
 Gleason VIII 8 (10.7)